Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo khoa học: "Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. | Available online http ccforum.eom content 9 4 R331 Research Drotrecogin alfa activated in patients with severe sepsis presenting with purpura fulminans meningitis or meningococcal disease a retrospective analysis of patients enrolled in recent clinical studies Jean-Louis Vincent1 Simon Nadel2 Demetrios J Kutsogiannis3 RT Noel Gibney4 S Betty Yan5 Virginia L Wyss6 Joan E Bailey7 Carol L Mitchell8 Samiha Sarwat9 Stephen M Shinall10 and Jonathan M Janes11 1Head Department of Intensive Care University of Brussels Erasme Hospital Brussels Belgium 2Consultant in Paediatric Intensive Care Department of Paediatrics Imperial College London St. Mary s Hospital London UK 3Assistant Professor Department of Public Health Sciences Division of Critical Care Medicine University of Alberta Royal Alexandra Hospital Edmonton Alberta Canada 4Professor Division of Critical Care Medicine University of Alberta University of Alberta Hospital Edmonton Alberta Canada 5Research Fellow Lilly Research Laboratories Indianapolis IN USA 6Associate Consultant Project Management Lilly Research Laboratories Indianapolis IN USA 7Clinical Development Associate Lilly Research Laboratories Indianapolis IN USA 8Associate Global Medical Information Consultant Lilly Research Laboratories Indianapolis IN USA 9Statistician Lilly Research Laboratories Indianapolis IN USA 10Scientific Communications Associate Lilly Research Laboratories Indianapolis IN USA Medical Advisor Lilly Research Centre Erl Wood Manor Windlesham Surrey UK Corresponding author Jonathan M Janes jonathan.janes@lilly.com Received 28 Jan 2005 Revisions requested 24 Feb 2005 Revisions received 4 Apr 2005 Accepted 8 Apr 2005 Published 1 7 May 2005 Critical Care 2005 9 R331-R343 DOI 10.1186 cc3538 This article is online at http ccforum.com content 9 4 R331 2005 Vincent et al. licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by .